This report describes a case of IgO lambda myeloma which was discovered only following investigation of a suspicious 'low gamma region'. If anti-IgO investigations had not been carried out, it may have been misinterpreted as Bence Jones myeloma. The case illustrates that evaluation of serum and urine in cases of suspected myeloma is mandatory and that the possibility of IgO myeloma in cases that appear to be 'free light chain' paraproteins only should be investigated.
IgO myeloma is a rare form of B-cell dyscrasia. It constitutes 1-2% of all reported cases of myeloma. I It has a male predominance and usually affects younger people, the most common features being anaemia, bone pain, hepatosplenomegaly, lymphadenopathy and a relatively high incidence of renal failure associated with Bence Jones proteinuria." This case illustrates the ease with which the diagnosis may be missed if the laboratory fails to investigate a suggestive immunoglobulin profile.
PATIENT HISTORY
MW, a 59-year-old woman, presented as an acute medical admission following a loss of consciousness at home and left-sided weakness on awaking. Previous medical history was complex, including hypotension, cholangitis and removal of gallstones, gastric ulcer, appendectomy and hysterectomy. She had experienced three cerebrovascular accidents, all affecting movement on her left side. She was a diabetic, controlled on diet. She also suffered from schizophrenia and depression. None of her clinical history was suggestive of a B-cell dyscrasia.
INVESTIGATIONS
Full blood count showed a slight lymphopenia (1,0 x J09; reference range I· 5-4 x J09) but was otherwise normal; the erythrocyte sedimentation rate was 44mm/h. Urea and electrolytes and bone, renal and liver profiles were all normal.
Correspondence: Dr D Sinclair. E-mail: davidsinclair(alQMAILOI.porthosp-swest.nhs.uk 564 Skeletal survey was normal. Her immunoglobulin (lg) profile was: IgG, 3·5g/L (reference range 6-16); IgA, 0·4 g/L (reference range 0·8-4); IgM, 1·0 giL (reference range 0'5-2). Protein electrophoresis showed a mild hypogammaglobulinaemia but no obvious paraprotein present. On the basis of this immunoglobulin profile, immunofixation of the serum was requested using our usual panel of antibodies, which includes anti-IgG, IgA, IgM, kappa and lambda light chains. This showed the presence of a small lambda light-chain band in the p-region. Immunofixation studies of an early morning urine showed the presence of a similar band which reacted with lambda light-chain antisera only and ran in a similar p-region position to that of the serum band. The initial thought was that this was a free light-chain band occurring in both serum and urine. However, on retesting the serum using anti-lgO antiserum the presence of an IgO lambda band in the fJ-region was demonstrated. The position of the band in the fJ-region, and the fact that it was obscured by the fJ-region proteins, meant that scanning densitometry did not give an accurate assessment of the amount of paraprotein; however, it was probably less than 5 giL. The serum fJ2-microglobulin concentration was 2·8 giL (reference range < 2-4g/L), The urine band did not react with anti-I gO antiserum. A bone marrow aspirate showed the presence of marrow plasmacytosis with 18% of plasma cells scattered throughout the sample and occasionally occurring in clusters. Immunostaining of this sample showed strong IgO staining of these plasma cells and that they were lambda lightchain restricted. They formed solid sheets in places; this is the picture normally associated with myeloma and not monoclonal gammopathy of undetermined significance in which there is Usually little if any bone marrow plasmacytosis.
The final diagnosis was smouldering IgD lambda myeloma, a finding that did not relate to her presenting symptoms.
DISCUSSION
The interpretation of serum electrophoresis and immunoglobulin profiles forms an important part of the investigation of immune function. This is usually carried out by laboratory staff prior to issuing a final report to the clinician. It is often the responsibility of laboratory staff, therefore, to instigate further investigation of suspicious immunoglobulin profiles. This case illustrates a suspicious hypogammaglobulinaemia that was not readily explained by the clinical data. All adult patients with unexplained hypogammaglobulinaemia should have a serum and urine protein electrophoresis performed to exclude the presence of a serum paraprotein which may indicate myeloma. On this occasion, What at first appeared to be a 'free light chain' band was discovered in both the serum and urine. Often, Bence Jones protein migrates to a different position in the electrophoresis gel compared with an intact immunoglobulin arising from the same neoplastic clone, and this can give a clue that these para proteins seen in serum and urine are not identical. This did not happen in this case as both serum and urine paraproteins migrated into the f3-region and could easily have been assumed to be the same protein occurring in serum and urine, i.e. consistent with a lightchain myeloma. This further illustrates that examination of both serum and urine is a mandatory procedure.
The vast majority of IgD para proteins so far described are lambda light-chain restricted and many laboratories have a routine irnrnuno-fixation panel like ours which looks for the most common paraproteins (IgG, IgA, IgM, kappa and lambda). IgD may not be tested routinely and the possibility exists that these paraproteins will be missed and an erroneous diagnosis of free lambda light chains made.
The correct identification of an IgD paraprotein is not merely an academic exercise as there are prognostic differences between a true Bence Jones lambda myeloma and myeloma associated with an intact immunoglobulin molecule, the former being associated with a worse prognosis.' IgD myeloma occurs only very rarely (in 1-2% of cases), with the most common being IgG myeloma (in 60% of cases). The IgD paraprotein is often labile and easily subject to proteolytic degradation in serum. This can contribute to the low amounts seen in serum, which are often difficult to detect. The rarity of this form and the difficulties in detection mean that many laboratories may classify these cases as Bence Jones myeloma, whereas in fact they may be producing an intact IgD molecule.
This case serves as a timely reminder that serum and urine should be examined to investigate myeloma and that all paraproteins that appear to be free light chains only should be tested for IgE and IgD reactivity, especially the latter, if they appear to be lambda light chains.
